Management of tumor lysis syndrome in patients with multiple myeloma during bortezomib treatment.
Wang L et al. Clin J Oncol Nurs. 2015 Feb 1;19(1):E4-7. doi: 10.1188/15.CJON.E4-E7.
Meta-analysis of incidence and risk of peripheral neuropathy associated with intravenous bortezomib.
Peng L et al. Support Care Cancer. 2015 Feb 13. [Epub ahead of print].
Renal insufficiency retains adverse prognostic implications despite renal function improvement following Total Therapy for newly diagnosed multiple myeloma.
Khan R et al. Leukemia. 2015 Feb 2. doi: 10.1038/leu.2015.15. [Epub ahead of print].
A challenging diagnosis: crystal-storing histiocytosis in plasma cell myeloma.
Lee JS et al. Am J Clin Pathol. 2015 Feb;143(2):300-4. doi: 10.1309/AJCPC7RWYPYG8UGY